FORTE BIOSCIENCES INC (FBRX) Stock Analyst Ratings
NASDAQ:FBRX - Nasdaq - US34962G2084 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 82% to FBRX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 60.18. This target is 825.85% above the current price.
FBRX was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about FBRX.
In the previous month the buy percentage consensus was at a similar level.
FBRX was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-04-01 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-01-21 | TD Cowen | Initiate | Buy |
| 2024-12-04 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-11-15 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-08-19 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-05-30 | Brookline Capital | Initiate | Buy |
| 2024-04-08 | Ladenburg Thalmann | Upgrade | Neutral -> Buy |
| 2021-09-20 | Chardan Capital | Upgrade | Sell -> Neutral |
| 2021-09-03 | Chardan Capital | Downgrade | Buy -> Sell |
| 2021-09-03 | Ladenburg Thalmann | Downgrade | Buy -> Neutral |
| 2021-09-03 | Brookline Capital | Downgrade | Buy -> Hold |
| 2021-09-03 | B. Riley Securities | Downgrade | Buy -> Neutral |
| 2021-09-03 | Truist Securities | Downgrade | Buy -> Hold |
| 2021-05-14 | B. Riley Securities | Initiate | Buy |
| 2021-03-26 | Citigroup | Initiate | Buy |
| 2021-03-17 | Chardan Capital | Maintains | Buy |